SCHEMBL2160086

SCHEMBL2160086

CCOC(=O)c1nc(S(C)(=O)=O)ncc1Br

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.71
▸ TP53 P04637 5/20 0.71
▸ TLR9 Q9NR96 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ HTT P42858 2/20 0.71
▸ NPC1 O15118 1/20 0.71
▸ XBP1 P17861 1/20 0.71
▸ MAPK1 P28482 1/20 0.71
▸ NPSR1 Q6W5P4 1/20 0.71
▸ HSD17B10 Q99714 1/20 0.71
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ GLP1R P43220 1/20 0.45
▸ TARBP2 Q15633 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28283383 0.84 TLR9 (0.49) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL9423075 0.80 ALDH1A1 (0.44) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL18528954 0.79 TP53 (0.46) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL15955800 0.78 HSP90AA1 (0.54) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL21679019 0.78 MAPT (0.49) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL30667736 0.78 MAPT (0.49) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL4763594 0.78 MAPT (0.63) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL31456656 0.77 TP53 (0.44) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL6866134 0.77 NPC1 (0.42) MAPTTP53TLR9ALDH1A1HTT
SCHEMBL2160733 0.75 MEN1 (0.54) MAPTTP53TLR9ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526098-B1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES HOFFMANN LA ROCHE (CH) 2018-07-11 — — EP disclosed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 — — EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 — — US disclosed
US-8623866-B2 — — 2014-01-07 — — US disclosed
US-8470820-B2 Nitrogen-containing heteroaryl derivatives HOFFMAN-LA ROCHE INC. (US) 2013-06-25 — — US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 — — EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — US disclosed
US-20110183979-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-07-28 — — US disclosed
WO-2011089132-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A MAPT 4100/4885TP53 4670/4885TLR9 3425/4885
US-20110183979-A1 NITROGEN-CONTAINING HETEROARYL DERIVATIVES PDE3A, PDE2A, PDE10A MAPT 4445/4885TP53 4773/4885TLR9 2990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback